Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-06 Sale | 2023-03-08 4:26 pm | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer | 690 | $15.26 | $10,532 | 268,854 (Direct) | View |
| 2023-02-28 Sale | 2023-03-02 7:03 pm | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer | 2,005 | $15.96 | $32,002 | 254,644 (Direct) | View |
| 2022-07-08 Sale | 2022-07-12 7:30 pm | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer | 2,197 | $25.41 | $55,835 | 256,649 (Direct) | View |
| 2022-04-21 Sale | 2022-04-21 6:32 pm | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer | 2,197 | $20.42 | $44,872 | 257,229 (Direct) | View |
| 2022-03-04 Sale | 2022-03-07 8:47 pm | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer | 856 | $16.85 | $14,420 | 294,726 (Direct) | View |
| 2022-03-01 Sale | 2022-03-03 4:18 pm | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer | 775 | $17.75 | $13,758 | 246,982 (Direct) | View |
| 2021-03-01 Sale | 2021-03-03 4:50 pm | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer | 780 | $34.57 | $26,968 | 237,253 (Direct) | View |
| 2020-12-14 Sale | 2020-12-16 3:15 pm | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer | 15,000 | $30 | $450,000 | 375,489 (Indirect Direct) | View |
| 2020-09-29 Sale | 2020-10-01 9:01 pm | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer | 15,000 | $30 | $450,000 | 389,235 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-02 Option Award | 2023-03-06 6:56 pm | N/A 2033-03-02 | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer | 54,400 | $0 | 309,044 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-07 8:47 pm | N/A 2032-03-03 | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer | 48,600 | $0 | 294,726 (Direct) | View |
| 2021-03-03 Option Award | 2021-03-05 3:52 pm | N/A 2031-03-03 | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer | 38,300 | $0 | 275,553 (Direct) | View |
| 2020-12-18 Ownership | 2021-02-16 7:29 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer | 12,500 | $0 | 238,033 (Direct) | View |
Ownership | 2021-02-16 7:29 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer | 0 | $0 | 238,033 (Indirect) | View |
| 2020-02-27 Option Award | 2020-03-03 9:06 pm | N/A 2030-02-27 | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer | 21,000 | $0 | 416,235 (Direct) | View |
| 2020-02-04 Conversion | 2020-02-04 6:24 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer | 24,991 | $0 | 395,235 (Direct) | View |
Ownership | 2020-01-30 8:06 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer | 0 | $0 | 469,211 (Direct) | View |